A transformative new health initiative has begun across the North East and North Cumbria as NHS leaders roll out...
Lire la suiteSeaport Therapeutics has officially dosed the first patient in its eagerly anticipated phase 2b BUOY-1 trial of GlyphAllo, a...
Lire la suiteMüller UK & Ireland has announced a major investment into its West Lancashire operations, revealing plans to pour £45...
Lire la suiteIn a significant leap forward for the field of bacteriophage therapy, BiomX has published promising results from its phase...
Lire la suiteBiotech company Osivax has reached a significant milestone in its mission to transform influenza prevention, with new phase 2a...
Lire la suiteA beloved name in British brewing is going greener than ever. Oakham Ales, based in Peterborough, is preparing to...
Lire la suite